Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Selective or nonselective ET antagonists for pulmonary hypertension?

Feb. 8, 2001

Collgard and Mayo Clinic sign second agreement for halofuginone development

Feb. 8, 2001

FDA extends approval of Toprol-XL to include heart failure

Feb. 7, 2001

TCV-309 improves organ dysfunction and morbidity, but not mortality, in septic shock

Feb. 7, 2001

Orion claims new use for levosimendan

Feb. 6, 2001

MAA for UT-15 filed in France; new name accepted

Feb. 6, 2001

Sustained beneficial effects seen for ALT-711 on arterial and ventricular parameters in aged monkeys

Feb. 6, 2001

Bispidine antiarrhythmic agents from AstraZeneca

Feb. 5, 2001

Influence of EGIS-7229 on myocardial refractoriness to electrical stimulation

Feb. 5, 2001

BSF-302146 may have potential for preventing restenosis following CABG surgery

Feb. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...